Prevention and treatment of peripheral neuropathy
US5420112A · kind A · utility
53Cited by
2References
13Claims
0Family size
Inventors
Key dates
| Filing date | Apr 16, 1993 |
| Grant date | May 30, 1995 |
| Priority date | — |
| Expiry date | Apr 16, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features a method of preventing or treating a peripheral neuropathy that results from a systemic disease (e.g., post-polio syndrome) or a toxic agent (e.g., a chemotherapeutic agent), and that is not caused by an abnormal insulin level in a mammal. The method involves administering a neuropathy-reducing amount of insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to the mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.